Gyros Protein Technologies
This new host cell protein (HCP) kit is designed for automated impurity analysis of biotherapeutics expressed in E. coli systems. The kit is optimized for use in Gyrolab® systems and has been developed as part of a licensing and supply agreement with Cygnus Technologies (part of Maravai LifeSciences), incorporating their E. coli HCP antibodies and other reagents. The kit quantifies HCP impurities from E. coli expression systems used in the production of biotherapeutics, a critical step in ensuring the efficacy and safety of the drug molecule. This ready-to-use kit is a key tool for the automated analysis of bioprocess samples, offering further support to customers working in biotherapeutics process development and manufacturing.
